Last update:
Oncology & Cancer news
Oncology & Cancer
Electrotherapy using injectable nanoparticles offers hope for glioblastoma treatment
Electrotherapy using injectable nanoparticles delivered directly into the tumor could pave the way for new treatment options for glioblastoma, according to a new study from Lund University in Sweden.
15 hours ago
0
2
Oncology & Cancer
Landscape of KRAS mutations and targeted therapies in colorectal cancer mapped in new study
A team of researchers from the Germans Trias i Pujol Research Institute (IGTP) and Institut Català d'Oncologia (ICO) has studied alterations in the KRAS gene in colorectal cancer by combining genomic analyses with a systematic ...
15 hours ago
0
0
Compounded imiquimod ointment may be beneficial for some ocular surface cancers
Compounded imiquimod 5% ointment may be safe and effective for diffuse conjunctival melanoma in situ (MIS) or ocular surface squamous neoplasia (OSSN), according to a case series study published online Nov. 26 in JAMA Ophthalmology.
11 hours ago
0
0
Mini lung organoids made in bulk could help test personalized cancer treatments
A team of scientists have developed a simple method for automated manufacturing of lung organoids which could revolutionize the development of treatments for lung disease. These organoids, miniature structures containing ...
Dec 1, 2025
0
2
Study reveals alarming number of invasive breast cancers in younger women
A study of data from seven outpatient facilities in the New York region found that 20–24% of all the breast cancers diagnosed during an 11-year period were found in women aged 18 to 49, according to research being presented ...
Dec 1, 2025
0
1
Lung cancer should no longer be defined by fear and stigma, experts say
For decades, lung cancer has been associated with stigma, anxiety, and loss. Advances in screening, therapeutics, and survivorship have created a new reality; lung cancer is treatable, survivable, and increasingly understood ...
Dec 1, 2025
0
0
Research highlights areas for improvement in palliative care for adolescents, young adults with cancer
Adolescents and young adults (AYAs) with cancer have unique needs compared with other age groups. Access to palliative care among this age group remains challenging. New research published in CMAJ (Canadian Medical Association ...
Dec 1, 2025
0
0
Predicting a rare but life-altering complication of common cancer treatment
A new study published in the Journal of Clinical Investigation has identified biomarkers that predict the likelihood of a patient developing checkpoint inhibitor-associated autoimmune diabetes before they are treated with ...
Nov 29, 2025
0
0
Drug combination sidesteps resistance in aggressive childhood neuroblastoma models
A discovery from Australian researchers could lead to better treatment for children with neuroblastoma, a cancer that currently claims 9 out of 10 young patients who experience recurrence. The team at the Garvan Institute ...
Nov 28, 2025
0
0
Histotripsy: How sound waves could impact tumor treatment
For anyone facing cancer, the treatment options can feel brutally familiar: surgery, radiotherapy, chemotherapy, or a combination of them all. But a new approach is beginning to offer something very different. By using nothing ...
Nov 28, 2025
0
1
Potential new second-line option for advanced biliary tract cancer identified
Biliary tract cancers, including intrahepatic, perihilar, and extrahepatic cholangiocarcinoma and gallbladder cancer, are among the most aggressive gastrointestinal malignancies. Treatment options remain limited once the ...
Nov 28, 2025
0
0
Cognitive decline common after treatment for slow-growing brain tumors, study finds
Slow-growing brain tumors, known as IDH mutated gliomas, have a relatively good prognosis. Treatment may include surgery, radiotherapy and chemotherapy. However, a recent study, published in the journal Neuro-Oncology, shows ...
Nov 28, 2025
0
0
Simple blood test formula identifies patients at high risk of liver cancer
A new scoring system using common clinical parameters accurately identifies chronic liver disease patients with a significantly increased risk of developing liver cancer. This tool acts as a universal predictor, helping doctors ...
Nov 28, 2025
0
0
Rural Australians are 13% less likely to survive cancer. Here's what needs to change
If you live in rural or remote Australia and are diagnosed with cancer, you're less likely to survive than someone in the city with the same disease. Our research shows people in rural Australia are 13% less likely to survive ...
Nov 28, 2025
0
0
Missing cancer gene explains why some lung tumors respond well to immunotherapy
For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study published in Cell Reports, Mayo Clinic researchers have found several previously unknown genetic and ...
Nov 26, 2025
0
2
High risk of metastatic recurrence found among young cancer patients
A new study of adolescents and young adults (AYAs) with seven common cancers reveals that nearly one in ten patients diagnosed with non-metastatic disease later develop metastatic recurrence—a condition associated with ...
Nov 26, 2025
0
11
Study finds uneven burden of brain and nervous system cancers across US
A new nationwide study has revealed striking differences in how brain and nervous system cancers affect Americans depending on where they live, as well as their age, sex and socioeconomic status, according to the study published ...
Nov 26, 2025
0
0
Scientists develop one-product-fits-all immunotherapy for pancreatic cancer
Pancreatic cancer is among the deadliest forms of cancer, with most patients diagnosed after the disease has already spread throughout the body. The five-year survival rate for metastatic cases hovers around 2–3%, and median ...
Nov 25, 2025
0
114
Myeloid mimicry enables kidney tumors to resist immunotherapy and worsen rapidly, study finds
Researchers at The University of Texas MD Anderson Cancer Center have found that renal medullary carcinoma (RMC) cells use an adaptive mechanism called "myeloid mimicry" to hide from the immune system and promote disease ...
Nov 25, 2025
0
14
Cracking gastric cancer's metabolic code: Blocking cholesterol pathways slows tumor growth by 65% in mice
A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has made a breakthrough in gastric cancer research, revealing how the "second brain"—nerves in the digestive system, also known as ...
Nov 25, 2025
0
7
Shapeshifting tumors unmasked: New insights into master regulators reveal therapeutic vulnerabilities
Some tumors are almost impossible to treat. That's especially true for carcinomas, which don't behave like other malignancies. Some of these tumors act as shapeshifters and start to resemble cells from other organs of the ...
Nov 25, 2025
0
50
Calcium-sensitive switch boosts the efficacy of cancer drugs
Cancer-fighting antibody drugs are designed to penetrate tumor cells and release a lethal payload deep within, but too often they don't make it that far. A new study shows how this Trojan Horse strategy works better by exploiting ...
Nov 25, 2025
0
15
Many men may not need long-term hormone therapy for prostate cancer, study suggests
A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of androgen deprivation therapy (ADT) for prostate cancer occur within the first 9 to 12 months. Extending ...
Nov 25, 2025
0
2
HER2-targeted therapy shows promising results in rare bile duct cancers
Zanidatamab, a bispecific HER2-targeted antibody, delivered clinically meaningful and durable responses for patients with HER2-positive biliary tract cancer (BTC), according to final results from the HERIZON-BTC-01 clinical ...
Nov 25, 2025
0
0
Tattoos could be a risk factor for melanoma
An increasing number of Swedes are getting tattoos and Sweden's population is now one of the most tattooed in Europe. At the same time, the incidence of melanoma is increasing. A new epidemiological study from Lund University ...
Nov 25, 2025
0
0
